logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Frank R Masiarz

This inventor holds 18 USPTO granted patents. Top assignees: Chiron Corporation, Nordisk Gentofte, Novartis Vaccines & Diagnostics, Gmbh. Active years: 1987-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank R Masiarz. Retrieved from https://idiyas.com/inventor/frank-r-masiarz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 88.9

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 169(Granted Patents)


Company Filing History:

goldMedal16 out of 672 
 
Chiron Corporation
 patents
silverMedal2 out of 2 
 
Nordisk Gentofte
 patents
bronzeMedal1 out of 245 
 
Novartis Vaccines & Diagnostics, Gmbh
 patents
4. 1 out of 1,802 
 
Novo Nordisk A/s
 patents
where one patent can have more than one assignee

Years Active: 1987-2007

Loading Chart...
18 patents (USPTO):Explore Patents
1. 7247452 - Truncated keratinocyte growth factor (KGF) having increased biological activity (2007-07-24),
2. 7138505 - Factor VIII:C nucleic acid molecules (2006-11-21),
3. 7084119 - Truncated keratinocyte growth factor (KGF) having increased biological activity (2006-08-01),
4. 6677301 - Truncated keratinocyte growth factor (KGF) having increased biological activity (2004-01-13),
5. 6074848 - Truncated keratinocyte growth factor (KGF) having increased biological (2000-06-13),
6. 6025465 - Insulin-like growth factor binding protein (IGFBP-6) (2000-02-15),
7. 5872220 - Antibodies to insulin-like growth factor binding protein IGFBP-6 (1999-02-16),
8. 5863767 - Truncated keratinocyte growth factor (KGF) having increased biological (1999-01-26),
9. 5843883 - Methods of wound healing and treating hyperproliferative diseases of (1998-12-01),
10. 5783671 - Method and composition for preparation of factor VIIIC (1998-07-21),
11. 5773586 - Conjugates comprising truncated keratinocyte growth factor (KGF) having (1998-06-30),
12. 5677278 - Truncated keratinocyte growth factor (KGF) having increased biological (1997-10-14),
13. 5635374 - Bone calcification factor and recombinant production of the factor (1997-06-03),
14. 5620867 - Bone morphogenetic protein expression and DNA (1997-04-15),
15. 5212074 - Genetic material encoding new insulin-like growth factor binding protein (1993-05-18),

Title: The Inventor Frank R Masiarz: Pioneering Innovations in San Francisco

Introduction: Frank R Masiarz is a distinguished inventor based in San Francisco, CA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Frank R Masiarz holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Frank R Masiarz has consistently pushed the boundaries of traditional thinking, leading to the development of cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Frank R Masiarz has collaborated with leading experts, researchers, and companies to bring his inventions to life, fostering a culture of innovation and excellence in the process.

Conclusion: Frank R Masiarz's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving an indelible mark on the world of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…